Sign In
Buy IVA
$4.04
-0.0500 (-1.22%)
At Close: Jun 03, 2026
Inventiva announces the closing of $107.7 million initial public offering on the Nasdaq Global Market
06:40pm, Wednesday, 15'th Jul 2020
Daix (France), July 15, 2020 – INVENTIVA S.A. (Euronext Paris: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral.
U.S. IPO Weekly Recap: Preclinical Biotech Nkarta Pops 166% In A 5 IPO Week
08:22am, Sunday, 12'th Jul 2020
Three biotechs, two Chinese issuers, and one SPAC went public this past week. Preclinical oncology biotech Nkarta popped 166% in the best first-day return for a $10+ million IPO since 2015.
Inventiva announces trading resumption of its ordinary shares on Euronext Paris
12:30pm, Friday, 10'th Jul 2020
Daix (France), July 10, 2020 – INVENTIVA S.A. (Euronext Paris: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the.
Inventiva announces the pricing of its initial public offering on the Nasdaq Global Market
06:00am, Friday, 10'th Jul 2020
Daix (France), July 10, 2020 – INVENTIVA S.A. (Euronext Paris: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral.
U.S. IPO Week Ahead: Third Quarter Kicks Off With China's Largest Gay Dating App
02:05pm, Friday, 03'rd Jul 2020
BlueCity Holdings plans to raise $85 million at a $614 million market cap. Quhuo plans to raise $27 million at a $450 million market cap. Nkarta plans to raise
Inventiva SA Starts U.S. IPO Rollout
03:52pm, Friday, 26'th Jun 2020
Inventiva SA has filed to raise $90 million in a U.S. IPO. The firm is advancing a pipeline of treatment candidates for NASH, MPS and other diseases. IVA is pre
U.S. IPO Weekly Recap: Royalty Pharma Takes The Crown In 5 IPO Week
11:05am, Saturday, 20'th Jun 2020
Five IPOs and one SPAC went public this past week led by Royalty Pharma. Healthcare continued to dominate, with all five IPOs coming from the sector. Seven IPOs
